You have 9 free searches left this month | for more free features.

L2 adult acute lymphoblastic leukemia

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Undifferentiated Leukemia, B-cell Adult Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia Trial

Completed
  • Acute Undifferentiated Leukemia
  • +13 more
  • Chicago, Illinois
    Cancer and Leukemia Group B
Apr 5, 2022

Acute Lymphoid Leukemia, Minimal Residual Disease, Gene Abnormality Trial in São Paulo (Prednisone, Vincristin, Daunorubicin)

Recruiting
  • Acute Lymphoid Leukemia
  • +3 more
  • São Paulo, SP, Brazil
    Instituto do Cancer do Estado de Sao Paulo
Jul 24, 2023

Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia Trial in Tianjin (Vincristine, Daunorubicin, Cyclophosphamide)

Recruiting
  • Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia
  • Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Dec 13, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Adult Acute Lymphoblastic

Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 31, 2022

B-cell Acute Lymphoblastic Leukemia Trial (HY004, Cyclophosphamide, Fludarabine Phosphate)

Not yet recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • HY004
  • +2 more
  • (no location specified)
Aug 18, 2023

Burkitt Lymphoma, Lymphoblastic Lymphoma, Adult, Acute Lymphoblastic Leukemia, Adult Trial in Zhuhai (Thiotepa,

Recruiting
  • Burkitt Lymphoma
  • +2 more
  • Thiotepa, cyclophosphamide, cladribine, and cytarabine conditioning regimen
  • Zhuhai, Guangdong, China
    The Fifth Affiliated Hospital of Sun Yat-sen University
Sep 25, 2023

T-Acute Lymphoblastic Leukemia, Adult T Lymphoblastic Lymphoma Trial in United States (BL-8040, Nelarabine)

Terminated
  • T-Acute Lymphoblastic Leukemia
  • Adult T Lymphoblastic Lymphoma
  • Saint Louis, Missouri
  • +1 more
Jan 18, 2023

Leukemia Trial in Portland (cyclophosphamide, cytarabine, dexamethasone)

Terminated
  • Leukemia
  • Portland, Oregon
    OHSU Knight Cancer Institute
Dec 13, 2022

Patients Who Received Inotuzumab Ozogamicin for B-cell ALL That

Not yet recruiting
  • Adult Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia
  • Inotuzumab Ozogamicin
  • (no location specified)
Nov 3, 2022

Adult Acute Lymphocytic Leukemia Trial in Frankfurt (Depocyt, Dexamethasone)

Completed
  • Adult Acute Lymphocytic Leukemia
  • Frankfurt, Germany
    University Hospital, Medical Dept. II
Aug 16, 2022

Lymphoblastic Leukemia in Children Trial (induction: vincristine, L-asparaginase, dexamethasone, intrathecal Ara-C, intrathecal

Not yet recruiting
  • Lymphoblastic Leukemia in Children
  • induction: vincristine, L-asparaginase, dexamethasone, intrathecal Ara-C, intrathecal Methotrexate
  • +7 more
  • (no location specified)
Oct 24, 2023

Determining the Mechanisms of Loss of CAR T Cell Persistence

Not yet recruiting
  • Acute Lymphoblastic Leukemia With Failed Remission
  • +4 more
    • (no location specified)
    Mar 29, 2023

    Acute Lymphoblastic Leukemia, Adult, Ph+ ALL, Newly Diagnosed Trial in Czechia (Ponatinib 15 MG Oral Tablet)

    Active, not recruiting
    • Acute Lymphoblastic Leukemia, Adult
    • +2 more
    • Ponatinib 15 MG Oral Tablet
    • Brno, Czechia
    • +6 more
    Nov 30, 2022

    Acute Lymphoblastic Leukemia, Adult Trial in Caba (Evaluation of survival and toxicities in AYA Ph-negative ALL patients

    Recruiting
    • Acute Lymphoblastic Leukemia, Adult
    • Evaluation of survival and toxicities in AYA Ph-negative ALL patients treating in first line depending on risk category.
    • Paraná, Entre Ríos, Argentina
    • +1 more
    Dec 29, 2022

    B-Cell Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia Trial in Tampa (Tecartus)

    Recruiting
    • B-Cell Lymphoblastic Leukemia
    • Acute Lymphoblastic Leukemia
    • Tampa, Florida
      Moffitt Cancer Center
    Nov 28, 2023

    B Acute Lymphoblastic Leukemia, Ph-Negative ALL, High Risk Acute Lymphoblastic Leukemia Trial (Azacitidine Injection,

    Not yet recruiting
    • B Acute Lymphoblastic Leukemia
    • +2 more
    • Azacitidine Injection
    • +2 more
    • (no location specified)
    Oct 15, 2023

    Acute Lymphoblastic Leukemia, Adult, Invasive Fungal Infections Trial in Rome (observation of invasive fungal infections)

    Recruiting
    • Acute Lymphoblastic Leukemia, Adult
    • Invasive Fungal Infections
    • observation of invasive fungal infections
    • Rome, Italy
      Fondazione Policlinico Universitario A. Gemelli IRCCS
    Feb 20, 2023

    Acute Lymphocytic Leukemia, Adult Lymphoblastic Lymphoma Trial in United States (DNR, VCR, PEG-asp)

    Terminated
    • Acute Lymphocytic Leukemia
    • Adult Lymphoblastic Lymphoma
    • La Jolla, California
    • +3 more
    Apr 26, 2022

    Clinical Significance of Occult Central Nervous System

    Recruiting
    • Acute Lymphoblastic Leukemia
    • cerebrospinal fluids exams
    • Roma, RM, Italy
      Tor Vergata University
    Mar 17, 2023

    Lymphoblastic Leukemia, Acute, Adult, Ph Negative ALL, Newly Diagnosed Trial in Czechia (Blinatumomab)

    Active, not recruiting
    • Lymphoblastic Leukemia, Acute, Adult
    • +2 more
    • Brno, Czechia
    • +4 more
    Aug 3, 2022

    Acute Lymphoblastic Leukemia Trial in New York (Venetoclax)

    Recruiting
    • Acute Lymphoblastic Leukemia
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Feb 2, 2023

    Survival in Adult MRD Positive Acute Lymphoblastic Leukemia

    Completed
    • Acute Lymphoblastic Leukemia
      • Brno, Czechia
      • +9 more
      Sep 12, 2022

      Lymphoblastic Leukemia Trial in Palo Alto (Dexamethasone, Mitoxantrone, PEG asparaginase)

      Not yet recruiting
      • Lymphoblastic Leukemia
      • Palo Alto, California
        Stanford University
      Apr 27, 2023

      Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome

      Active, not recruiting
      • Acute Lymphoblastic Leukemia
      • +15 more
      • Laboratory Biomarker Analysis
      • +3 more
      • Chicago, Illinois
      • +2 more
      Jan 12, 2023